Loading chat...

LA SB253

Bill

Official Source

Status

Introduced

2/26/2026

Primary Sponsor

Patrick McMath

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Prohibits professional and occupational licensing boards from preventing healthcare providers with prescriptive authority from providing patients with peptides

  • Peptides must be shipped from FDA-registered 503B facilities or 503A compounding pharmacies that purchase active pharmaceutical ingredients from FDA-registered manufacturers

  • Prescribing providers must verify that any peptides prescribed are not on the FDA's prohibited compounding list

  • Effective August 1, 2026

Legislative Description

Provides relative to peptides. (8/1/26)

PUBLIC HEALTH

Last Action

Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.

3/16/2026

Committee Referrals

Health & Welfare2/26/2026

Full Bill Text

No bill text available